Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Volasertib

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Notable Labs Gets FDA Clearance For Volasertib Phase 2 Study
    Notable Labs Gets FDA Clearance For Volasertib Phase 2 Study

    24 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/24/2917910/0/en/Notable-Labs-Receives-FDA-Clearance-to-Proceed-Further-with-Volasertib-Phase-2-Study.html

    GLOBENEWSWIRE
    24 Jul 2024
    Share Share
    Notable Labs Outlines PPMP-Enabled AML Trial at AACR 2024
    Notable Labs Outlines PPMP-Enabled AML Trial at AACR 2024

    09 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/09/2860412/0/en/Notable-Labs-Presents-the-Design-Plan-for-the-PPMP-Enabled-Phase-2-Trial-with-Volasertib-for-Relapsed-Refractory-AML-at-AACR-2024.html

    GLOBENEWSWIRE
    09 Apr 2024
    Share Share
    Notable Advances Volasertib Phase 2 Program
    Notable Advances Volasertib Phase 2 Program

    22 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/22/2833635/0/en/Notable-Advances-Volasertib-Phase-2-Program-Utilizing-Proprietary-Predictive-Precision-Medicine-Platform-Guided-Enrollment.html

    GLOBENEWSWIRE
    22 Feb 2024
    Share Share
    Oncoheroes Biosciences & BI sign exclusive licensing agreement for volasertib
    Oncoheroes Biosciences & BI sign exclusive licensing agreement for volasertib

    16 Sep 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncoheroes-biosciences-inc-and-boehringer-ingelheim-international-gmbh-sign-exclusive-licensing-agreement-for-volasertib-300917504.html

    PR NEWSWIRE
    16 Sep 2019
    Share Share